Outcome of HIV-infected patients on peritoneal dialysis: Experience in a center and literature review;Evolución de los pacientes infectados por el VIH en diálisis peritoneal: Experiencia de un centro y revisión de la literatura

Nefrologia

Volumn 28, Issue 5, 2008, Pages 505-510

  Rivera Gorrin, M ^a   Merino Rivas, J L ^a   Alarcon Garcelan M C ^a   Galeano Alvarez C ^c   Manuel, O ^b   Teruel Briones, J L ^a   Marcen Letosa R ^a   Ortuno Mirete J ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^c Hospital Ramón Y Cajal ^*

Author keywords

Antiretroviral therapy; HIV; Peritoneal dialysis; Peritonitis; Survival

Indexed keywords

ADULT; ARTICLE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MIDDLE AGED; MORTALITY; PERITONEAL DIALYSIS; SURVIVAL RATE;

ADULT; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; SURVIVAL RATE;

EID: 53049094508     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998; 338 (13): 853-60.
2. Graham MM, Bonini LA, Verdi MM. A multi-center study: clinical practices of HIV infected patients on CAPD/CCPD. Adv Perit Dial 1990; 6: 88-91.
3. Soleymanian T, Raman S, Shannaq FN, Richardson R, Jassal SV, Bargman J, Oreopoulos DG. Survival and morbidity of HIV patients on hemodialysis and peritoneal dialysis: one center's experience and review of the literature. Int Urol Nephrol 2006; 38 (2): 331-8.
4. Khanna R, Tachopoulou OA, Fein PA, Chattopadhyay J, Avram MM. Survival experience of peritoneal dialysis patients with human immunodeficiency virus: a 17-year retrospective study. Adv Perit Dial 2005; 21: 159-63.
5. Kimmel PL, Umana WO, Simmens SJ, Watson J, Bosch JP. Continuous ambulatory peritoneal dialysis and survival of HIV infected patients with end-stage renal disease. Kidney Int 1993; 44 (2): 373-8.
6. Tebben JA, Rigsby MO, Selwyn PA, Brennan N, Kliger A, Finkelstein FO. Outcome of HIV infected patients on continuous ambulatory peritoneal dialysis. Kidney Int 1993; 44 (1): 191-8.
7. Ahuja TS, Collinge N, Grady J, Khan S. Is dialysis modality a factor in survival of patients with ESRD and HIV-associated nephropathy? Am J Kidney Dis 2003; 41 (5): 1060-4.
8. Ortiz C, Meneses R, Jaffe D, Fernández JA, Pérez G, Bourgoignie JJ. Outcome of patients with human immunodeficiency virus on maintenance hemodialysis. Kidney Int 1988; 34 (2): 248-53.
9. Perinbasekar S, Brod-Miller C, Pal S, Mattana J. Predictors of survival in HIV-infected patients on hemodialysis. Am J Nephrol 1996; 16 (4): 280-6.
10. Feinfeld DA, Kaplan R, Dressler R, Lynn RI. Survival of human immunodeficiency virus-infected patients on maintenance dialysis. Clin Nephrol 1989; 32 (5): 221-4.
11. Rodríguez RA, Mendelson M, O'Hare AM, Hsu LC, Schoenfeld P. Determinants of survival among HIV-infected chronic dialysis patients. J Am Soc Nephrol 2003; 14 (5): 1307-13.
12. Atta MG, Fine DM, Kirk GD, Metha SH, Moore RD, Lucas GM. Survival during renal replacement theraphy among africans americans infected with HIV type I in urban Baltimore, Maryland. AIDS. 2007 (Dec): 45.
13. Hammer SM, Saag MS, Schechter M, Montaner JS, Schooley RT, Jacobsen DM, Thompson MA, Carpenter CC, Fischl MA, Gazzard BG, Gatell JM, Hirsch MS, Katzenstein DA, Richman DD, Vella S, Yeni PG, Volberding PA; International AIDS Society-USA Panel. Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel. JAMA 2006; 296 (7): 827-43.
14. Lowe SH, Hassink EA, Van Eck-Smit BL, Borleffs JC, Lange JM, Reiss P. Stavudine but not didanosine as part of HAART contributes to peripheral lipoatrophy: a substudy from the Antiretroviral Regimen Evaluation Study (ARES). HIV Clin Trials 2007; 8 (5): 337-44.
15. Szczech LA, Kalayjian R, Rodríguez R, Gupta S, Coladonato J, Winston J. The clinical characteristics and antiretroviral dosing patterns of HIV-infected patients receiving dialysis. Kidney Int 2003; 63 (6): 2295-301.
16. Hammer SM, Saag MS, Schechter M, Montaner JS, Schooley RT, Jacobsen DM, Thompson MA, Carpenter CC, Fischl MA, Gazzard BG, Gatell JM, Hirsch MS, Katzenstein DA, Richman DD, Vella S, Yeni PG, Volberding PA; International AIDS Society-USA Panel. Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel. JAMA 2006; 296 (7): 827-43.
17. Panel de expertos de GESIDA; Plan Nacional sobre el Sida [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update January 2007)]. Enferm Infecc Microbiol Clin 2007; 25 (1): 32-53.
18. Schloth T, Genabe I, Pilgrim W, Jorden A, Fein PA, Avram MM. Peritonitis and the patient with human immunodeficiency virus (HIV). Adv Perit Dial 1992; 8: 250-2.
19. Wasser WG, Boyle MJ, Brandon S, Gruber SJ, Winston RV, Feldman NS. HIV positivity does not predispose peritoneal dialysis patients to peritonitis (Abstract). J Am Soc Nephrol 1991; 2: 369.
20. Dressler R, Peters AT, Lynn RI. Pseudomonal and candidal peritonitis as a complication of continuous ambulatory peritoneal dialysis in human immunodeficiency virus-infected patients. Am J Med 1989; 86 (6 Pt 2): 787-90.
21. Elsey RM, Carson RW, DuBose TD Jr. Pasteurella multocida peritonitis in an HIV-positive patient on continuous cycling peritoneal dialysis. Am J Nephrol 1991; 11 (1): 61-3.
22. Tan D, Fein PA, Jorden A, Avram MM. Successful treatment of tuberculous peritonitis while maintaining patient on CAPD. Adv Perit Dial 1991; 7: 102-4.
23. Kiernan L, Finkelstein FO, Kliger AS, Gorban-Brennan N, Juergensen P, Mooraki A, Brown E. Outcome of polymicrobial peritonitis in continuous ambulatory peritoneal dialysis patients. Am J Kidney Dis 1995; 25 (3): 461-4.
24. Ahuja TS, Grady J, Khan S. Changing trends in the survival of dialysis patients with human immunodeficiency virus in the United States. J Am Soc Nephrol 2002; 13 (7): 1889-93.
25. Wyatt CM, Murphy B. Kidney transplantation in HIV-infected patients. Semin Dial 2005; 18 (6): 495-8.
26. Ahuja TS, Borucki M, Grady J. Highly active antiretroviral therapy improves survival of HIV-infected hemodialysis patients. Am J Kidney Dis 2000; 36 (3): 574-80.
27. Chow KM, Szeto CC, Leung CB, Kwan BC, Law MC, Li PK. A risk analysis of continuous ambulatory peritoneal dialysis-related peritonitis. Perit Dial Int 2005; 25 (4): 374-9.
28. Crane HM, Van Rompaey SE, Kitahata MM. Antiretroviral medications associated with elevated blood pressure among patients receiving highly active antiretroviral therapy. AIDS 2006; 20 (7): 1019-26.
29. Bergersen BM. Cardiovascular risk in patients with HIV Infection: impact of antiretroviral therapy. Drugs 2006; 66 (15): 1971-87.
30. De Socio GV, Schillaci G. Hypertension in HIV patients. AIDS 2006; 20 (12): 1682-3.
31. Friis-Møller N, Weber R, Reiss P, Thiébaut R, Kirk O, D'Arminio Monforte A, Pradier C, Morfeldt L, Mateu S, Law M, El-Sadr W, De Wit S, Sabin CA, Phillips AN, Lundgren JD; DAD study group. Cardiovascular disease risk factors in HIV patients - association with antiretroviral therapy. Results from the DAD study. AIDS 2003; 17 (8): 1179-93.
32. Jones R, Sawleshwarkar S, Michailidis C, Jackson A, Mandalia S, Stebbing J, Bower M, Nelson M, Gazzard BG, Moyle GJ. Impact of antiretroviral choice on hypercholesterolaemia events: the role of the nucleoside reverse transcriptase inhibitor backbone. HIV Med 2005; 6 (6): 396-402.
33. DAD Study Group, Friis-Møller N, Reiss P, Sabin CA, Weber R, Monforte A, El-Sadr W, Thiébaut R, De Wit S, Kirk O, Fontas E, Law MG, Phillips A, Lundgren JD. Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med 2007; 356 (17): 1723-35.
34. Abbott KC, Swanson SJ, Agodoa LY, Kimmel PL. Human immunodeficiency virus infection and kidney transplantation in the era of highly active antiretroviral therapy and modern immunosuppression. J Am Soc Nephrol 2004; 15 (6): 1633-9.
35. Trullás JC, Miró JM, Barril G, Ros S, Burgos FJ, Moreno A, Mazuecos A, Álvarez-Vijande R, Oppenheimer F, Carmen Sánchez M, Blanco JL, Tuset M, Torre-Cisneros J, Polo R, González J. Renal transplantation in patients with HIV infection. Enferm Infecc Microbiol Clin 2005; 23 (6): 363-74.
36. Mazuecos A, Pascual J, Gómez E, Sola E, Cofán F, López F, Puig-Hooper CE, Baltar JM, González-Molina M, Oppenheimer F, Marcén R, Rivero M. Trasplante renal en pacientes con infección HIV en España. Nefrología 2006; 26 (1): 113-20.
37. Wyatt CM, Murphy B. Kidney transplantation in HIV-infected patients. Semin Dial 2005; 18 (6): 495-8.